About
Vibe Bio is an investment firm that focuses on BioTech startups developing promising therapeutics. Founded with the aim to foster innovation in the health sector, Vibe Bio leverages proprietary artificial intelligence to analyze and invest in biotech companies from pre-seed through Series A stages. The firm takes a particular interest in platform technologies and rare or overlooked diseases. VibeOne, the firm's software platform, uses AI to assist in biopharma strategic decisions, including generating TPP benchmarks, performing PTRS & risk assessments, tracking competitive intelligence, prioritizing portfolio programs, and conducting financial valuations. Beyond investments, Vibe Bio produces a content series called VibeCast, hosting discussions with biotech founders, regulatory experts, and patient Community advocates to explore current trends in drug development.